Literature DB >> 17484066

Effect of quinpirole on timing behaviour in the free-operant psychophysical procedure: evidence for the involvement of D2 dopamine receptors.

T H C Cheung1, G Bezzina, C L Hampson, S Body, K C F Fone, C M Bradshaw, E Szabadi.   

Abstract

RATIONALE: Operant timing behaviour is sensitive to dopaminergic manipulations. It has been proposed that this effect is mediated principally by D(2)-like dopamine receptors. However, we recently found that the effect of d-amphetamine on timing in the free-operant psychophysical procedure was mediated by D(1)-like dopamine receptors. It has not been established whether stimulation of D(2)-like receptors affects timing in this schedule.
OBJECTIVE: To examine the effects of a D(2)-like receptor agonist quinpirole on second-range timing and the ability of dopamine receptor antagonists to reverse quinpirole's effects.
MATERIALS AND METHODS: Rats responded on two levers (A and B) under a free-operant psychophysical schedule in which reinforcement was provided intermittently for responding on A during the first half, and B during the second half, of 50-s trials. Logistic functions were fitted to the relative response rates [percent responding on B (%B) vs time (t)] under each treatment; quantitative timing indices [T (50) (value of t when %B = 50) and Weber fraction] were compared among treatments.
RESULTS: Quinpirole (0.04, 0.08 mg kg(-1)) reduced T (50). This effect was attenuated by D(2)-like receptor antagonists haloperidol (0.05, 0.1 mg kg(-1)), eticlopride (0.04, 0.08 mg kg(-1)) and sulpiride (30, 60 mg kg(-1)), but not by the D(3) receptor-preferring antagonist nafadotride (0.5, 1 mg kg(-1)), the D(4) receptor antagonist L-745870 (1, 3 mg kg(-1)) or the D(1)-like receptor antagonist SKF-83566 (0.015 mg kg(-1)).
CONCLUSIONS: Results suggest that quinpirole reduced T (50) via an action at D(2) receptors. D(1)-like and D(2)-like receptors may mediate behaviourally similar but pharmacologically distinct effects on timing behaviour.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17484066     DOI: 10.1007/s00213-007-0798-8

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.415


  75 in total

1.  Shifts in the psychometric function and their implications for models of timing.

Authors:  A Machado; P Guilhardi
Journal:  J Exp Anal Behav       Date:  2000-07       Impact factor: 2.468

Review 2.  Toward a neurobiology of temporal cognition: advances and challenges.

Authors:  J Gibbon; C Malapani; C L Dale; C Gallistel
Journal:  Curr Opin Neurobiol       Date:  1997-04       Impact factor: 6.627

3.  The influence of `switching' on the psychometric function in the free-operant psychophysical procedure.

Authors:  T J Chiang; A S Al-Ruwaitea; M Y Ho; C M Bradshaw; E Szabadi
Journal:  Behav Processes       Date:  1998-12       Impact factor: 1.777

4.  Affinity for the dopamine D2 receptor predicts neuroleptic potency in decreasing the speed of an internal clock.

Authors:  W H Meck
Journal:  Pharmacol Biochem Behav       Date:  1986-12       Impact factor: 3.533

5.  Behavioural effects in the rat of the putative dopamine D3 receptor agonist 7-OH-DPAT: comparison with quinpirole and apomorphine.

Authors:  R Depoortere; G Perrault; D J Sanger
Journal:  Psychopharmacology (Berl)       Date:  1996-04       Impact factor: 4.530

6.  D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons.

Authors:  C R Gerfen; T M Engber; L C Mahan; Z Susel; T N Chase; F J Monsma; D R Sibley
Journal:  Science       Date:  1990-12-07       Impact factor: 47.728

7.  The dopamine D3 receptor mediates locomotor hyperactivity induced by NMDA receptor blockade.

Authors:  Ludovic Leriche; Jean-Charles Schwartz; Pierre Sokoloff
Journal:  Neuropharmacology       Date:  2003-08       Impact factor: 5.250

8.  Comparative pharmacology of human dopamine D(2)-like receptor stable cell lines coupled to calcium flux through Galpha(qo5).

Authors:  Robert B Moreland; Masaki Nakane; Diana L Donnelly-Roberts; Loan N Miller; Renjie Chang; Marie E Uchic; Marc A Terranova; Earl J Gubbins; Rosalind J Helfrich; Marian T Namovic; Odile F El-Kouhen; Jeffrey N Masters; Jorge D Brioni
Journal:  Biochem Pharmacol       Date:  2004-08-15       Impact factor: 5.858

9.  A comparative in vitro and in vivo pharmacological characterization of the novel dopamine D3 receptor antagonists (+)-S 14297, nafadotride, GR 103,691 and U 99194.

Authors:  V Audinot; A Newman-Tancredi; A Gobert; J M Rivet; M Brocco; F Lejeune; L Gluck; I Desposte; K Bervoets; A Dekeyne; M J Millan
Journal:  J Pharmacol Exp Ther       Date:  1998-10       Impact factor: 4.030

10.  Effects of dopamine agonists and antagonists on locomotor activity in male and female rats.

Authors:  Charles W Schindler; Gilberto N Carmona
Journal:  Pharmacol Biochem Behav       Date:  2002-07       Impact factor: 3.533

View more
  6 in total

1.  Evidence for the sensitivity of operant timing behaviour to stimulation of D1 dopamine receptors.

Authors:  T H C Cheung; G Bezzina; C L Hampson; S Body; K C F Fone; C M Bradshaw; E Szabadi
Journal:  Psychopharmacology (Berl)       Date:  2007-08-01       Impact factor: 4.530

2.  Attenuation of the effects of d-amphetamine on interval timing behavior by central 5-hydroxytryptamine depletion.

Authors:  S Body; T H C Cheung; C L Hampson; F S den Boon; G Bezzina; K C F Fone; C M Bradshaw; E Szabadi
Journal:  Psychopharmacology (Berl)       Date:  2008-11-19       Impact factor: 4.530

3.  Fos expression in the orbital prefrontal cortex after exposure to the fixed-interval peak procedure.

Authors:  L Valencia-Torres; C M Olarte-Sánchez; S Body; K C F Fone; C M Bradshaw; E Szabadi
Journal:  Behav Brain Res       Date:  2012-01-24       Impact factor: 3.332

4.  Neuroprotection by Exendin-4 Is GLP-1 Receptor Specific but DA D3 Receptor Dependent, Causing Altered BrdU Incorporation in Subventricular Zone and Substantia Nigra.

Authors:  A Harkavyi; N Rampersaud; P S Whitton
Journal:  J Neurodegener Dis       Date:  2013-11-21

5.  Systemic administration of 8-OH-DPAT and eticlopride, but not SCH23390, alters loss-chasing behavior in the rat.

Authors:  Robert D Rogers; Adeline Wong; Chris McKinnon; Catharine A Winstanley
Journal:  Neuropsychopharmacology       Date:  2013-01-07       Impact factor: 7.853

6.  Fos expression in the prefrontal cortex and ventral striatum after exposure to a free-operant timing schedule.

Authors:  L Valencia-Torres; C M Olarte-Sánchez; S Body; T H C Cheung; K C F Fone; C M Bradshaw; E Szabadi
Journal:  Behav Brain Res       Date:  2012-08-16       Impact factor: 3.332

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.